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Objective. Oxidized cholesterol derivatives are thought to exert atherogenic effect thus adversely affecting vascular endothelium.
The aim of the study was to assess the effect of 5α,6α-epoxycholesterol on experimentally induced hypercholesterolemia in
rabbits, and the levels of homocysteine (HCY), asymmetric dimethylarginine (ADMA), paraoxonase-1 (PON-1), and
inflammatory parameters (IL-6, TNF-α, CRP). Material and methods. The rabbits were divided into 3 groups, 8 animals each,
and fed with basic fodder (C), basic fodder plus cholesterol (Ch) or basic fodder plus 5α,6α-epoxycholesterol, and unoxidized
cholesterol (ECh). Serum concentrations of studied parameters were determined at 45-day intervals. The study was continued
for six months. Results. We demonstrated that adding 5α,6α-epoxycholesterol to basic fodder significantly affected lipid status of
the experimental animals, increasing total cholesterol and LDL cholesterol levels, as well as HCY and ADMA levels, whilst
leaving the PON-1 activity unaffected. Additionally, the ECh group presented with significantly higher concentrations of
inflammatory biomarkers (IL-6, TNF-α, and CRP). In the Ch group, lower yet significant (as compared to the C group) changes
of levels of studied parameters were observed. Conclusion. Exposure of animals with experimentally induced
hypercholesterolemia to 5α,6α-epoxycholesterol increases dyslipidaemia, endothelial dysfunction, and inflammatory response.
1. Introduction
Cardiovascular disease (CVD) is the leading cause of death in
Europe and the United States. Heart disease, stroke, and
hypertension are currently recognized to be caused, in part,
by arterial endothelial dysfunction. Endothelial dysfunction
may occur much earlier than the clinical manifestation of
cardiovascular diseases [1].
A healthy vascular endothelium remains in a tightly
regulated balance between pro and antioxidants, vasodilators
and vasoconstrictors, pro and anti-inflammatory molecules,
and pro and antithrombotic signals. Dysfunctional endothe-
lium, though, displays prooxidant, vasoconstrictor, proin-
flammatory, and prothrombotic properties [1–3].
Oxysterols are cholesterol oxidation products formed
through enzymatic or autoxidation mechanisms. They
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may be originally present in food containing animal fat,
but they are chiefly generated during food storing and
cooking. These compounds show a biochemical reactivity
that is one or even two orders of magnitude higher than
that of the parent compound. Furthermore, unlike choles-
terol, oxysterols are able to permeate through lipophilic
membranes [4, 5].
Oxysterols can affect many cellular functions and influ-
ence various physiological processes (e.g., cholesterolmetabo-
lism,membranefluidity regulation, and intracellular signaling
pathways). They are implicated in a number of pathologies,
including type2diabetesmellitus, neurodegenerativediseases,
inflammatory bowel disease, or degenerative changes within
the retina. It has also been suggested that oxysterols may play
a role in malignancies such as breast, prostate, colon, and bile
duct cancer [5–7]. Furthermore, it has been postulated that
oxysterols may play a role in atherosclerosis [8, 9].
In light of such findings, the primary aim of the
study was to assess the effect of dietary oxysterols on
vascular endothelium.
2. Material and Methods
2.1. Animals. The protocol was approved by the Bioethical
Committee for Animal Experimentation of the Medical
University of Silesia in Katowice, Poland (approval number
27/2007, dated April 17th 2007). All animals received
humane care in compliance with the 8th edition of the Guide
for the Care and Use of Laboratory Animals published by the
National Institute of Health [10].
Twenty-four male Chinchilla rabbits (b.m. 2870± 20 g)
were obtained from the Center for Experimental Medicine,
Medical University of Silesia in Katowice. The animals were
housed individually in stainless steel metabolic cages under
a 12-hour light/dark cycle. The rabbits were fed proper
fodder (80 g/kg) once a day, allowed unlimited access to
water, and weighed at 45-day intervals.
The rabbits were divided into three groups of eight
animals each, according to the following scheme:
(1) Control group (C): rabbits fed only a basal diet (BD)
(2) Cholesterol group (Ch): rabbits fed BD with 0.5%
cholesterol, 5% sunflower oil, and 2% porcine lard
(3) Oxidized cholesterol group (ECh): rabbits fed BD
with 5α,6α-epoxycholesterol acetate equal to 250mg
free 5α,6α-epoxycholesterol/kg BD, 0.5% cholesterol,
5% sunflower oil and 2% porcine lard. Daily
estimated dose of oxysterol in ECh group was about
10–15mg/kg
The specific diets for each group were prepared weekly
and stored in a freezer at −20°C. The BD was composed of
24% protein, 69% carbohydrate, and 7% fat of the total
energy content of the diet. Groups fed BD with cholesterol
(Ch group) and 5α,6α-epoxycholesterol (ECh group)
received 19% of energy from proteins, 42% from carbohy-
drates, and 39% from fat, respectively. The current study
was continued for six months.
2.2. Synthesis of 5α,6α-Epoxycholesterol Acetate. 5α,6α-
Epoxycholesterol acetate was synthetized from cholesterol
acetate (Sigma-Aldrich, USA) by oxidation with m-
chloroperoxybenzoic acid (Sigma-Aldrich, USA) as described
byMcCarthy [11]. Next, oxidation product mixture was puri-
fied by column chromatography on silica gel with the use of
chloroform-acetone (4 : 1, v/v) as mobile phase. Fractions
containing pure esterwere controlled byTLC technique (silica
gel plates, solvent as above), pooled, and dried under vacuum.
2.3. Blood Sample Collection. At the beginning of experiment
(following the acclimatization period) and at 45-day intervals
thereafter, 10mL blood samples were collected from ear veins
of each animal to plain and EDTA tubes (Sarstedt, S-Monov-
ette) in a total of six samplings. For serum preparation, sam-
ples were allowed to clot and centrifuge (15min, 1500g). The
serum was analyzed instantly (lipid parameters and PON-1
activity) or stored deep frozen at −75°C (other assays).
Plasma from EDTA tubes was separated immediately after
sampling (15min, 1500 g, 4°C) and stored at −75°C.
2.4. Biochemical Analyses
2.4.1. Lipid Profile Parameters Concentrations. Total choles-
terol and triacylglycerol concentrations were assayed using
a standard enzymatic method (Emapol, Poland). HDL cho-
lesterol was determined using an enzymatic method after
precipitation of other lipoproteins with phosphotungstic acid
(Emapol, Poland). For LDL cholesterol assay, QUANTOLIP
LDL kit (Technoclone, Austria) was used. All analyses were
performed using the EM280 biochemical analyzer (Emapol,
Poland). Interassay and intra-assay coefficients of variation
(CV) were below 3% and 5%, respectively, for all parameters.
2.4.2. Endothelial Dysfunction Markers
(1) Total Homocysteine Concentration. Total homocysteine
(tHCY) plasma concentration was estimated using the HPLC
method with spectrofluorimetric detection according to Kuo
et al. [12] and Minniti et al. [13]. HPLC separations were
conducted on LC-10ATVP chromatograph (Shimadzu,
Japan) equipped with RF-10AXL detector (Shimadzu, Japan)
and SUPELCOSIL RP-18 column (4.6 x 150mm, 5 μm,
Supelco, USA). Inter and intra-assay coefficients (CV) of var-
iation were 7.7% and 11.2%, respectively.
(2) Asymmetric Dimethylarginine Concentration. Asymmet-
ric dimethylarginine (ADMA) plasma concentration was
determined using the HPLC method as described previously
[14, 15]. Assays were performed on Nucleosil Phenyl column
(25× 4.6mm; 7 μm; Supelco, USA) and Shimadzu chromato-
graph with spectrofluorimetric detector (as described above).
Inter and intra-assay coefficients (CV) of variation were 7.2%
and 10.9%, respectively.
(3) Paraoxonase-1 Activity. Paraoxonase-1 (PON-1) serum
activity was assayed using the kinetic method with paraoxon
(o,o-diethyl-o-(p-nitrophenyl)-phosphate; Sigma, USA) as a
substrate [16]. Determinations were performed at 37°C on
TECHNICON RA-XT™ analyzer (Technicon Instruments
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Corporation, USA). For cholinesterase inactivation, physo-
stigmine salicylate (eserine) was added to serum samples prior
to theassay.Oneunit (1 IU)ofPON-1 is theamountof enzyme
sufficient to decompose 1 micromole of substrate per minute
under testing conditions. Inter and intra-assay coefficients
(CV) of variation were 2.6% and 4.4%, respectively.
2.4.3. Inflammatory Markers
(1) C-Reactive Protein Concentration. C-reactive protein
(CRP) serum concentration was determined using ELISA
assay with use the immunoaffinity purified, hen antirabbit
CRP antibody as a capture antibody, rabbit CRP reference
serum as a standard, and biotinylated CCRP-15A-Z antibody
(all reagents were from Immunology Consultants Laboratory
Inc., USA) along with streptavidin-horseradish peroxidase
conjugate (DakoCytomation, Denmark) for the immuno-
complex detection. Inter and intra-assay coefficients of vari-
ation were 5% and 7.6%, respectively.
(2) Tumor Necrosis Factor α Concentration. The concentra-
tion of rabbit tumor necrosis factor α (TNF-α) in serum was
measured using ELISA method with goat antirabbit TNF-α
antibody as a capture antibody, biotinylated, monoclonal
antirabbit TNF-α antibody (both from BD PharMingen,
USA), and streptavidin-horseradish peroxidase conjugate
(DakoCytomation, Denmark) as a tracer. The assay was
performed according to the manufacturer’s instruction and
calibrated with the use of rabbit TNF-α (BD PharMingen,
USA). Results were presented as pg of TNF-α per mL of
serum [pg/mL]. Inter and intra-assay coefficients of variation
were 6.4% and 8.9%, respectively.
2.5. Statistical Analyses. Statistical analysis was performed
using STATISTICA 10.0 PL (StatSoft, Poland, Cracow) and
StataSE 12.0 (StataCorp LP, TX, U.S.) bundles and R
software. p value below 0.05 was considered as statistically
significant. All tests were two tailed. Imputations were not
done for missing data. Nominal and ordinal data were
expressed as percentages, whilst interval data were expressed
as mean value± standard deviation if normally distributed or
as median/interquartile range if the distribution was skewed
or nonnormal. Distribution of variables was evaluated by
the Shapiro–Wilk test and homogeneity of variances was
assessed using the Levene test. The comparisons were made
using one-way parametric ANOVA with Tukey’s posthoc
test and one-way repeated measures ANOVA with contrast
analysis as a posthoc test.
3. Results
3.1. Animal Body Weight. The analysis of animal body weight
during the experiment demonstrated a statistically significant
growth inhibition in a group fed with 5α,6α-epoxycholesterol
acetate (ECh group) as compared to the control group.
There were no significant profile differences between the
C and Ch groups. Figure 1 shows measurement results,
and Table 1 shows the result of statistical analyses for
the studied variables.
3.2. Lipid Profile Parameters. Changes in total cholesterol and
LDL cholesterol during the experimental exposure to oxy-
sterols and cholesterol demonstrated significant differences
in concentration increase rates between the groups of exper-
imental animals. The fastest concentration increase was seen
in the group fed with both 5α,6α-epoxycholesterol and cho-
lesterol (ECh group). Total cholesterol and LDL cholesterol
levels in this group reached the plateau on day 90 and
remained unchanged thereafter. In a group fed with BD
and cholesterol only (Ch group), the concentration of the
markers in question increased at a slower rate to eventually
settle at a lower level. The total cholesterol and LDL choles-
terol concentration profiles in ECh group differed signifi-
cantly from those of the Ch group (see Figure 1 and
Table 1). Together, ECh and Ch groups had significantly
higher levels of total cholesterol and LDL cholesterol as com-
pared to the control group (C), where there was no change in
these parameters throughout the entire experiment.
The HDL cholesterol levels tended to increase in both
cholesterol-fed groups (ECh and Ch groups). The highest
increase of HDL cholesterol levels was noted in a group fed
with cholesterol-rich diet without oxysterols (Ch group).
Furthermore, there was a significant difference in HDL cho-
lesterol profile between ECh and Ch groups. The analysis of
HDL cholesterol concentration as a percentage of total cho-
lesterol did not demonstrate changes between the group
exposed to oxysterols and cholesterol versus the group
exposed to native cholesterol only (Figure 1 and Table 1).
Triacylglycerol levels varied in a nonspecific way with no
significant differences between the groups. There was a
significant variability between the individual time points
(collections). In a control group, triacylglycerol level at the
end of the experiment was significantly lower than the
baseline value, whereas in the two remaining groups, there
were no significant differences between the baseline and final
levels (Figure 1 and Table 1).
3.3. Endothelial Dysfunction Markers. The analysis of
changes in total plasma tHCY concentration in rabbits
demonstrated an increase tendency in a control group and
a marked significant increase in both cholesterol-fed groups.
The highest increase was observed in a group exposed addi-
tionally to 5α,6α-epoxycholesterol. The tHCY levels in this
group differed significantly from the only cholesterol-fed
group (Ch group) or the control group (Figure 2, Table 1).
Similar observations were made for plasma ADMA in
rabbits. The highest rate of ADMA concentration increase
was seen in ECh (Figure 2, Table 1).
Serum PON-1 activity in rabbits dropped significantly as
a result of exposure to dietary cholesterol. However, there
was no additional modulation of its activity by oxysterols,
as PON-1 levels decreased in the same manner in both
ECh group, exposed to oxycholesterol, and Ch group,
exposed to cholesterol. Figure 2 shows PON-1 activity at
subsequent time points, and Table 1 shows statistical
analysis of these results.
3.4. Inflammatory Markers. The analysis of changes in
inflammatory marker concentrations during experimental
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Figure 1: Time’s profile of body weight and concentrations of total cholesterol, LDL cholesterol, HDL cholesterol, HDL cholesterol as a
percentage of total cholesterol (% HDL), and triacylglycerols in rabbits exposed to 5α,6α-epoxycholesterol and cholesterol (ECh
group), cholesterol (Ch group), and fed with basal diet (C group).
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Table 1: Results of ANOVA analysis of parameters between groups and inside each group (between first and last sampling).
Parameter
Body
mass
Total
cholesterol
LDL
cholesterol
HDL
cholesterol
HDL
cholesterol
as percent
of total
cholesterol
Triacylglycerols tHCY ADMA PON-1 IL-6 TNF-α CRP
Differences between groups for all sampling (p values)
C–ECh <0.05 <0.001 <0.001 <0.01 <0.001 <0.05 <0.001 <0.001 NS <0.001 <0.001 <0.001
C–Ch NS <0.001 <0.001 <0.001 <0.001 <0.05 <0.05 <0001 <0.01 <0.001 <0.001 <0.001
ECh–Ch NS <0.001 <0.001 <0.01 NS NS <0.01 <0.001 NS <0.001 <0.001 NS
Differences inside each group between 0 day and 180 day (p values)
Ech <0.001 <0.001 <0.001 <0.01 <0.001 NS <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Ch <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 <0.001 <0.001 <0.05 <0.001 <0.001
C <0.001 NS NS NS NS <0.001 NS NS NS NS NS NS
NS: nonstatistically significant.
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Figure 2: Time’s profile of concentrations of total homocysteine (tHCY), asymmetric dimethylarginine (ADMA), and paraoxonase-1 (PON-
1) activity in rabbits exposed to 5α,6α-epoxycholesterol and cholesterol (ECh group), cholesterol (Ch group), and fed with basal diet (C group).
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rabbit exposure to cholesterol and its epoxy derivatives
demonstrated activation of acute phase response in studied
animals (see Figure 3 and Table 1). Changes in IL-6 levels
demonstrated a significant increase in its production follow-
ing an exposure to 5α,6α-epoxycholesterol as compared to
exposure to native cholesterol or basal diet. Its increase rate
and the ultimate level achieved in month 6 in the ECh group
were significantly higher than in the Ch and C groups,
respectively.
A similar pattern was observed for the serum TNF-α
concentration during the experimental exposure to epoxy-
cholesterol. The highest concentrations were achieved in ani-
mals exposed to 5α,6α-epoxycholesterol and cholesterol-rich
fodder. The TNF-α profile in the ECh group significantly
differed to the one of the control group and the group
receiving cholesterol-rich fodder (Ch). Although the cyto-
kine in question was also biosynthesized in the Ch group,
the increase rate and the ultimate TNF-α level were signifi-
cantly lower than in the ECh group.
The serum CRP concentration increased in a similar
manner in both groups exposed to cholesterol. The CRP
profiles of ECh and Ch groups were significantly different
to the one of the control group. There was no significant
difference in CRP profiles between the ECh and Ch groups
(see Figure 3 and Table 1).
4. Discussion
The results achieved during the current study demonstrated
changes in the lipid parameters, endothelial dysfunction
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Figure 3: Time’s profile of concentrations of IL-6, TNF-α, and C-reactive protein (CRP) in rabbits exposed to 5α,6α-epoxycholesterol and
cholesterol (ECh group), cholesterol (Ch group), and fed with basal diet (C group).
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markers (tHCY, ADMA, and PON-1), and selected inflam-
matory markers in rabbits fed with cholesterol-rich diet with
added oxidized cholesterol derivatives for 6 months. The
concentrations of all these markers were assessed several
times at 45-day interval, which undoubtedly adds value to
the current study, as the experiments reported so far
provided only baseline and end concentrations of these
parameters. Having reviewed the available literature, we
failed to identify a study to assess changes in serum biochem-
ical markers during exposure to cholesterol-rich diet and
oxysterols.
In our research, we found total cholesterol and LDL cho-
lesterol levels in rabbits fed with cholesterol-rich diet
increased several dozenfold, with the highest increase
observed in a group of animals fed with both cholesterol
and 5α,6α-epoxycholesterols. Both total cholesterol and
LDL cholesterol levels in this group of animals were signifi-
cantly higher than in those fed with unoxidized cholesterol.
Therefore, adding 5α,6α-epoxycholesterols to the fodder
increased plasma levels of total cholesterol and LDL choles-
terol. The study by Mahfouz et al. [17] did not confirm that
replacing native cholesterol with autooxidized cholesterol
leads to changes in the plasma lipid profile. The mechanisms
leading to these observable changes in plasma cholesterol
levels are difficult to explain, especially that most published
data support inhibition by oxysterols of HMG-CoA reduc-
tase activity, which should be reflected in decreased biosyn-
thesis of endogenous cholesterol. On the other hand, it can
be hypothesized that endogenous cholesterol in plasma of
rabbits with experimentally induced hypercholesterolemia
constitutes only a small share of total amount of cholesterol,
so it is bioavailability (intestinal absorption and excretion) of
exogenous, dietary cholesterol, which mainly affects the
blood concentration. Another possible explanation is that
5α,6α-epoxycholesterols exert their effect at the stage of
intestinal absorption, as with the unchanged plasma levels
of biliary acids (unpublished data), slowing of cholesterol
metabolite elimination appears less likely mechanism
contributing to increasing hypercholesterolaemia [18].
The analysis of changes in HDL cholesterol levels in
rabbit serum demonstrated that absolute concentrations of
this fraction increased heterogeneously in the groups
exposed to cholesterol, with the highest increase observed
in the Ch group. The difference between the ECh and Ch
groups, though, was nonsignificant when the comparison
was made between HDL cholesterol levels expressed as a
percentage of total cholesterol in a given group. This finding
indicates the increased HDL production in the liver in
response to increased dietary cholesterol intake, which is in
keeping with published data [19].
Analysing the results of tHCY and ADMA assays in a
rabbit model, it becomes clear that the exposure to oxidized
cholesterol derivatives and cholesterol leads to their gradual
plasma level elevation and increases endothelial dysfunction
as compared to the controls. The plasma levels of both tHCY
and ADMA were elevated following the exposure to oxyster-
ols and cholesterol. However, exposure to cholesterol only
also resulted in a significant elevation of these biomarkers.
Significant elevation of HCY and ADMA levels in a group
fed with fodder containing 5α,6α-epoxycholesterols, as
compared to the groups C and Ch, indirectly confirms addi-
tional effect of epoxycholesterols on tHCY and ADMA levels.
The HCY and ADMA levels in the ECh group were signifi-
cantly higher than in the Ch group. In the ECh group, plasma
ADMA levels tended to start increasing earlier and more
markedly, which can be attributed to the angiotoxic effect
of oxysterols on vascular endothelium or abnormal renal
ADMA elimination.
The analysis of IL-6 concentrations in our experimental
animals seems to suggest that IL-6 biosynthesis is regulated
by exogenous epoxycholesterols, as IL-6 concentrations
increased significantly faster to settle at a higher level in ani-
mals exposed to oxycholesterol as compared to the groups
Ch and C. In the group Ch, the IL-6 level in month 6 was
twice as low as in the ECh group. In the control group, it
remained unchanged throughout the experiment. The above
findings are comparable to those published previously
[20–22]. However, the values reported in individual papers
tend to differ markedly, potentially due to different assay
methods used. Due to the well-established role of IL-6 in pro-
moting atherosclerosis in humans, its increased biosynthesis
seen in a rabbit model (particularly marked in a group
exposed to oxysterols) appears to be a significant biomarker
suggestive of chronic vascular wall inflammation.
In our experiment, the TNF-α concentration in rabbits
exposed to unoxidized cholesterol significantly increased
over the first four months to stabilise over the subsequent
two months. In the group fed additionally with 5α,6α-epoxy-
cholesterol, the rate and extent of increase were significantly
higher with higher TNF-α levels in month 6.
Rabbits with experimentally induced hypercholesterol-
emia presented with elevated levels of TNF-α, IL-6, IL-1,
and selected endothelial dysfunction markers, as it was seen
in a rat model [23]. Direct exposure of HUVEC cells to
7-keto-, 7β-hydroxycholesterol, and 7α-hydroxycholesterol
resulted in an increased TNF-α production [24]. This
can explain elevated TNF-α levels in animals exposed to
oxysterols. However, the available literature lacks data on
the effect of 5α,6α-epoxycholesterol on biosynthesis of
inflammatory cytokines.
The elevated levels of CRP in animals with experimen-
tally induced hypercholesterolemia, demonstrated in the cur-
rent study, are consistent with the available published data
[20, 23, 25]. Additional intake of dietary 5,6-epoxycholesterol
did not affect CRP levels. There is data to confirm extrahe-
patic origin of CRP in rabbits with experimentally induced
hypercholesterolemia, as its synthesis in adipocytes was
shown to be inhibited by administering atorvastatin [26].
Perhaps, then, animal adipose tissue constitutes an alterna-
tive source of this protein in the plasma, which is true for
some proinflammatory cytokines, such as TNF-α. This
hypothesis, though, appears unlikely due to decreased weight
gain observed in animals exposed to oxysterols as compared
to animals in the groups C and Ch.
The current study has some limitations. Extrapolating
the findings of experimental research in animal models to
the risk of oxysterol intake by humans, it should be noted
that the intake of cholesterol derivatives in experimental
7Mediators of Inflammation
animals ranged between 2.5 to approx. 10mg/kg per day [27,
28], which translates into the intake of 175–700mg of oxy-
sterols per day in an adult and amounts to at least 100% of
typical cholesterol daily intake. Therefore, it is highly unlikely
that a diet of a modern individual can comply with these
assumptions. Another issue is interspecies differences
between experimental animals (usually rabbits, rodents, or
birds) and humans. A limitation of the current study is also
a relatively low number of experimental animals in each
group, which was guided by ethical considerations relevant
to animal research experiments.
5. Conclusions
Based on our findings, we conclude that having been
absorbed from the gastrointestinal tract and incorporated
in lipoprotein structures, oxidized cholesterol derivatives
exert cytotoxic effect on vascular endothelial cells, causing
endothelial dysfunction, the severity of which depends on
the duration of exposure. Combined administration of
oxysterols and cholesterol is likely to increase their angio-
toxic effect. At the same time, the inflammatory response
and dyslipidaemia increase in severity.
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